Abstract
Objective
Iatrogenic Creutzfeldt-Jakob disease (iCJD) is mainly associated with dura mater (DM) grafts and administration of human growth hormones (hGH). Data on disease course in DM-CJD are limited. We describe the clinical and diagnostic findings in this patient group with special emphasis on MRI signal alterations.
Methods
Ten DM-CJD patients were studied for their clinical symptoms and diagnostic findings. The MRIs were evaluated for signal increase of the cortical and subcortical structures.
Results
DM-CJD patients had a median incubation time of 18 years and median disease duration of 7 months. The majority of patients were MM homozygous at codon 129 of the prion protein gene (PRNP) and presented with gait ataxia and psychiatric symptoms. No correlation between the graft site and the initial disease course was found. The MRI showed cortical and basal ganglia signal increase each in eight out of ten patients and thalamic hyperintensity in five out of ten cases. Of interest, patients with thalamic signal increase were homozygous for methionine.
Conclusion
The MRI findings in DM-CJD largely resemble those seen in sporadic CJD, as the cortex and basal ganglia are mainly affected.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Brown P, Brandel JP, Preese M, Sato T (2006) Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67:389–393
Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens C, Van Duijn C, Zerr I (2006) Cerebrospinal fluid tests in the differential diagnosis of CJD. Neurology 67:637–643
Boutoleau C, Guillon B, Martinez F, Vercelletto M, Faure A, Feve JR (2003) Iatrogenic Creutzfeldt-Jakob disease subsequent to dural graft: persisting risk after 1987. Eur J Neurol 10:521–523
Croes EA, Jansen GH, Lemstra AW, Frijns CJ, van Gool WA, van Duijn CM (2001) The first two patients with dura mater associated Creutzfeldt-Jakob disease in the Netherlands. J Neurol 248:877–880
Kimura K, Nonaka A, Tashiro H, Yaginuma M, Shimokawa R, Okeda R, Yamada M (2001) Atypical form of dural graft associated Creutzfeldt- Jakob disease: report of a postmortem case with review of the literature. J Neurol Neurosurg Psychiatry 70:696–699
Lang CJ, Heckmann JG, Querner V, Neundorfer B, Kornhuber J, Buchfelder M, Kretzschmar H (2001) Disease latency in Creutzfeldt-Jakob disease via dural grafting: a case report. Eur J Epidemiol 17:1013–1014
Mochizuki Y, Mizutani T, Tajiri N, Oinuma T, Nemoto N, Kakimi S, Kiamoto T (2003) Creutzfeldt-Jakob disease with florid plaques after cadaveric dura mater graft. Neuropathology 23:136–140
Preusser M, Strobel T, Gelpi E, Eiler M, Broessner G, Schmutzhard E, Budka H (2006) Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. J Neurol Neurosurg Psychiatry 77:413–416
Wakisaka Y, Santa N, Doh-ura K, Kitamoto T, Ibayashi S, Iida M, Iwaki T (2006) Increased asymmetric pulvinar magnetic resonance imaging signals in Creutzfeld-Jakob disease with florid plaques following a cadaveric dura mater graft. Neuropathology 26:82–88
Fradkin JE, Schonberger LB, Mills JL, Gunn WJ, Piper JM, Wysowski DK, Thomson R, Durako S, Brown P (1991) Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 265:880–884
Hoshi K, Yoshino H, Urata J, Nakamura Y, Yanagawa H, Sato T (2000) Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 55:718–721
Lang CJ, Heckmann JG, Neundorfer B (1998) Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 160:128–139
Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, Mackenzie J, Estibeiro K, Green AJ, Knight RS (2000) Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 47:575–582
Iwasaki Y, Mimuro M, Yoshida M, Hashizume Y, Kitamoto T, Sobue G (2008) Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease. Neuropathology 28:51–61
Heath CA, Barker RA, Esmonde TFG, Harvery P, Roberts R, Trend P, Head MW, Smith C, Bell JE, Ironside JW, Will RG, Knight RSG (2006) Dura materassociated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 77:880–882
WHO (1998) Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec 47:361–365
Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105:244–252
Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J (1996) Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 53:913–920
Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767–778
Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156:51–56
Kretzschmar H, Sethi S, Földvári Z, Windl O, Querner V, Zerr I, Poser S (2003) Iatrogenic Creutzfeldt-Jakob Disease with florid plaques. Brain Pathol 13:245–249
Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, Knight R, Will R (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 24:1560–1569
WHO (2001) The Revision of the Surveillance Case Definition for Variant Creutzfeldt-Jakob Disease (vCJD): Report of a WHO Consultation Edinburgh, United Kingdom, 17 May 2001. Available at: http://www.who.int/ csr/resources/publications/bse/ whocdscsreph20015.pdf
Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, Yamada M (2007) Clinical features and diagnosis of dura mater graft associated Creutzfeldt-Jakob disease. Neurology 69:360–367
Kobayashi Y, Hirata K, Tanaka H, Yamada T (2003) Quinacrine administration to a patient with Creutzfeldt- Jakob disease who received a cadaveric dura mater graft – an EEG evaluation. Rinsho Shinkeigaku 43:403–408
Ukisu R, Kushihashi T, Kitanosono T, Fujisawa H, Takenaka H, Ohgiya Y, Gokan T, Munechika H (2005) Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. Am J Roentgenol 184:560–566
Antoine JC, Michel D, Bertholon P, Mosnier JF, Laplanche JL, Beaudry P, Hauw JJ, Veyret C (1997) Creutzfeldt- Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology 48:1451–1453
Croes EA, Roks G, Jansen GH, Nijssen PC, van Duijn CM (2002) Creutzfeldt- Jakob disease 38 years after diagnostic use of human growth hormone. J Neurol Neurosurg Psychiatry 72:792–793
Delisle MB, Fabre N, Rochiccioli P, Doerr-Schott J, Rumeau JL, Bes A (1993) Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study. Rev Neurol Paris 149:524–527
Hannah EL, Belay ED, Gambetti P, Krause G, Parchi P, Capellari S, Hoffman RE, Schonberger LB (2001) Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 56:1080–1083
Kopp N, Streichenberger N, Deslys JP, Laplanche JL, Chazot G (1996) Creutzfeldt-Jakob disease in a 52-yearold woman with florid plaques (letter). Lancet 348:1239–1240
Liscic RM, Brinar V, Miklic P, Barsic B, Himbele J (1999) Creutzfeldt-Jakob disease in a patient with a lyophilized dura mater graft. Acta Med Croatica 53:93–96
Martinez-Lage JF, Poza M, Sola J, Tortosa JG, Brown P, Cervenakova L, Esteban JA, Mendoza A (1994) Accidental transmission of Creutzfeldt- Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry 57:1091–1094
Nishida Y, Yamada M, Hara K, Tsunemi T, Yamawaki M, Shimokawa R, Okeda R, Tsutsumi T, Mizusawa H (2002) Creutzfeldt-Jakob disease after Jannetta’s operation with cadaveric dura mater graft: initial manifestations related to the grafted site. J Neurol 249:480–483
Pocchiari M, Masullo C, Salvatore M, Genuardi M, Galgani S (1992) Creutzfeldt-Jakob disease after noncommercial dura mater graft (letter). Lancet 340:614–615
Shimizu S, Hoshi K, Muramoto T, Homma M, Ironside JW, Kuzuhara S, Sato T, Yamamoto T, Kitamoto T (1999) Creutzfeldt-Jakob disease with floridtype plaques after cadaveric dura mater grafting. Arch Neurol 56:357–362
Takashima S, Tateishi J, Taguchi Y, Inoue H (1997) Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet 350:865–866
Takayama S, Hatsuda N, Matsumura K, Nakasu S, Handa J (1993) Creutzfeldt- Jakob disease transmitted by cadaveric dural graft: a case report. No Shinkei Geka 21:167–170
Thadani V, Penar PL, Partington J, Kalb R, Janssen R, Schonberger LB, Rabkin CS, Prichard JW (1988) Creutzfeldt- Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 69:766–769
Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E (1997) Panencephalopathic type of Creutzfeldt- Jakob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 63:524–527
Yamada S, Aiba T, Endo Y, Hara M, Kitamoto T, Tateishi J (1994) Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery 34:740–743
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar HA (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schröter A, Henkel K, Tschampa HJ, Windl O, Pfahlberg A, Steinhoff BJ, Gefeller O, A. KH, Poser S (2000) Current clinical diagnosis in CJD: identification of uncommon variants. Ann Neurol 48:323–329
Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, Dohura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Y (2004) Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 63:443–449
Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP (2005) Diffusion-weighted and fluidattenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 26:1551–1562
Tschampa HJ, Kallenberg K, Urbach H, Meissner B, Nicolay C, Kretzschmar HA, Knauth M, Zerr I (2005) MRI in the diagnosis of sporadic Creutzfeldt- Jakob disease: a study on inter-observer agreement. Brain 128:2026–2033
Kallenberg K, Schulz-Schaeffer WJ, Jastrow U, Poser S, Meissner B, Tschampa HJ, Zerr I, Knauth M (2006) Creutzfeldt-Jakob disease: Comparative Analysis of MR Imaging Sequences. Am J Neuroradiol 27:1459–1462
Schroeter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S (2000) Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease. Arch Neurol 57:1751–1757
Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, Meissner B, Collie DA, Roeber S, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I (2006) Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 129:2288–2296
Krasnianski A, Meissner B, Schulz- Schaeffer W, Kallenberg K, Bartl M, Heinemann U, Varges D, Kretzschmar H, Zerr I (2006) Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 63:876–880
Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura Y, Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, Yamada M (2005) Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 64:643–648
Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Seeger HE, Zerr I, Kretzschmar H, Jansen GH, Olsen E, Mitrova E, Alpérovitsch A, Brandel JP, Murray K, Will RG (2006) Determinants of diagnostic investigation results across the clinical spectrum of sporadic CJD. Brain 129:2278–2287
Yamashita M, Yamamoto T, Nishinaka K, Udaka F, Kameyama M, Kitamoto T (2001) Severe brain atrophy in a case of thalamic variant of sporadic CJD with plaque-like PrP deposition. Neuropathology 21:138–143
Zeidler M, Ironside JW (2000) The new variant of Creutzfeldt-Jakob disease. Rev Sci Tech 19:98–120
Gurau C, Zeghoudi AC, Atlaoui-Rabia S, Charitanski D, Mallecourt J (2005) Cerebral magnetic resonance imaging in iatrogenic Creutzfeldt-Jakob disease. Presse Med 34:1080–1081
Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368:2061–2067
Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, Will RG, Alpérovitsch A (2003) Distribution of codon 129 genotype in human growth hormone- treated CJD patients in France and the UK. Lancet 362:128–130
Deslys JP, Jaegly A, d’Aignaux JH, Mouthon F, de Villemeur TB, Dormont D (1998) Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease (letter). Lancet 351:1251
Huillard d’Aignaux J, Costagliola D, Maccario J, Billette de Villemeur T, Brandel JP, Deslys JP, Hauw JJ, Chaussain JL, Agid Y, Dormond D, Alpérovitch A (1999) Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 53:1197–1201
Brown P, Preece M, Brandel J-P, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashmann NR, d’Aignaux JH, Cervenáková L, Fradkin J, Schonberger LB, Collins SJ (2000) Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075–1081
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Meissner, B., Kallenberg, K., Sanchez-Juan, P. et al. MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease. J Neurol 256, 355–363 (2009). https://doi.org/10.1007/s00415-009-0026-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-0026-z